Yi Ping Rong
Chief Tech/Sci/R&D Officer bij HBM HOLDINGS LIMITED
Vermogen: - $ op 31-03-2024
Profiel
Yi Ping Rong is currently an Executive Director & Senior Vice President at Harbour BioMed (Shanghai) Co., Ltd.
and an Executive Director, Chief Scientific Officer & SVP at HBM Holdings Ltd.
Dr. Rong previously worked as a Member at The American Association of Cancer Research.
Dr. Rong holds a doctorate degree from Case Western Reserve University, conferred in 2008, and a graduate degree from East China University of Science & Technology, conferred in 2002.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HBM HOLDINGS LTD.
-.--% | 03-04-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Yi Ping Rong
| Bedrijven | Functie | Begin |
|---|---|---|
| HBM HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 05-05-2022 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Director/Board Member | - |
Eerdere bekende functies van Yi Ping Rong
| Bedrijven | Functie | Einde |
|---|---|---|
| The American Association of Cancer Research | Corporate Officer/Principal | - |
Opleiding van Yi Ping Rong
| Case Western Reserve University | Doctorate Degree |
| East China University of Science & Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
| The American Association of Cancer Research |
